Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001379747 | SCV001577606 | likely pathogenic | not provided | 2017-10-29 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change severely impairs the ability of FH to perform decay accelerating activity (PMID: 24847005). This variant has been reported in several individuals affected with atypical hemolytic uremic syndrome (PMID: 20203157, 23307876, 25006455, 26826462), in individuals affected with isolated glomerulonephritis with isolated C3 deposits (PMID:22456601), and shown to segregate with disease in a family with age-related macular degeneration (PMID: 24847005). This variant is present in population databases (rs757785149, ExAC 0.003%). This sequence change replaces arginine with cysteine at codon 53 of the CFH protein (p.Arg53Cys). The arginine residue is weakly conserved and there is a large physicochemical difference between arginine and cysteine. |
Institute of Human Genetics, |
RCV002256753 | SCV002526718 | pathogenic | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2022-05-27 | criteria provided, single submitter | clinical testing | _x000D_ Criteria applied: PS3, PM5_STR, PS4_SUP, PM1_SUP, PP3 identified in patient with polygenic aHUS together with variant in CFH (ClinVar-ID: 505831) |
Fulgent Genetics, |
RCV002488198 | SCV002777170 | likely pathogenic | Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450049 | SCV004180677 | likely pathogenic | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing |